AIP
XFOR icon

Ameritas Investment Partners’s X4 Pharmaceuticals XFOR Stock Holding History

Ameritas Investment Partners’s Portfolio XFOR Stock Details XFOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$34.3K Buy
+7,338
New +$30.1K ﹤0.01% 2475
2025
Q2 		– Sell
-339
Closed -$2.4K – 3359
2025
Q1 		$2.4K Hold
339
– – ﹤0.01% 3065
2024
Q4 		$7.46K Hold
339
– – ﹤0.01% 2973
2024
Q3 		$6.8K Hold
339
– – ﹤0.01% 2998
2024
Q2 		$5.9K Hold
339
– – ﹤0.01% 3022
2024
Q1 		$14.1K Hold
339
– – ﹤0.01% 2703
2023
Q4 		$8.53K Hold
339
– – ﹤0.01% 2884
2023
Q3 		$11.1K Hold
339
– – ﹤0.01% 2801
2023
Q2 		$19.7K Buy
+339
New +$17.4K ﹤0.01% 2572
2021
Q2 		– Sell
-33
Closed -$8K – 3247
2021
Q1 		$8K Hold
33
– – ﹤0.01% 2930
2020
Q4 		$6K Hold
33
– – ﹤0.01% 2947
2020
Q3 		$7K Hold
33
– – ﹤0.01% 2890
2020
Q2 		$9K Hold
33
– – ﹤0.01% 2783
2020
Q1 		$10K Hold
33
– – ﹤0.01% 2565
2019
Q4 		$11K Hold
33
– – ﹤0.01% 2707
2019
Q3 		$13K Buy
33
+31
+1,550% +$12.3K ﹤0.01% 2625
2019
Q2 		$1K Hold
2
– – ﹤0.01% 3039
2019
Q1 		$1K Hold
2
– – ﹤0.01% 2968
2018
Q4 		$1K Hold
2
– – ﹤0.01% 2982
2018
Q3 		$1K Hold
2
– – ﹤0.01% 3015
2018
Q2 		$1K Hold
2
– – ﹤0.01% 2998
2018
Q1 		$9K Buy
+2
New +$5.82K ﹤0.01% 2764

Other funds holding XFOR

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
SVCM
Saturn V Capital Management Austin, Texas $697M AUM 628.57% 1-Year Est. Return
EAM
Empery Asset Management New York $86.5M AUM
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Ameritas Investment Partners's XFOR Position: Q2 2026 in Review

Ameritas Investment Partners opened a new position in X4 Pharmaceuticals (XFOR) in Q2 2026: 7,338 shares worth $34.3K. The stake represents ﹤0.01% of the portfolio and ranks #2475 among its holdings. This is a return to the name: Ameritas Investment Partners previously reported a position in XFOR as recently as Q1 2025.

Ameritas Investment Partners first reported a position in XFOR in Q1 2018 and has held it in 22 quarters since. 89 funds tracked by Wall St. Rank hold XFOR as of Q2 2026.

  • Ameritas Investment Partners held 7,338 shares of X4 Pharmaceuticals worth $34.3K as of Q2 2026.
  • X4 Pharmaceuticals was a new Ameritas Investment Partners position in Q2 2026.
  • X4 Pharmaceuticals made up ﹤0.01% of Ameritas Investment Partners's portfolio in Q2 2026, its #2475 holding.
  • Ameritas Investment Partners first reported a position in X4 Pharmaceuticals in Q1 2018 and has held it in 22 quarters since.
  • 89 funds tracked by Wall St. Rank held X4 Pharmaceuticals as of Q2 2026.

Based on Ameritas Investment Partners's 13F filing for Q2 2026, filed 13 Aug 2026.